Clinical trial
Evaluation of the Initial Prescription of Ketamine and Milnacipran Forin Depression in Patients With a Progressive Disease
NCT02783430 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Initial Prescription of Ketamine and Milnacipran Forin Depression in Patients With a Progressive Disease
- Lead sponsor
- University Hospital, Lille
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 8, 2016
- Completion date
- March 8, 2024
- Enrollment
- 42 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
depression